Boston, MA, United States of America

Shoshoni Droz

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: 10X Genomics, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shoshoni Droz: Innovator in Nucleic Acid Detection

Introduction

Shoshoni Droz is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biological sample analysis, particularly in the detection of nucleic acid sequences. With a total of 2 patents, Droz has established himself as a key figure in innovative research.

Latest Patents

Droz's latest patents include "Compositions and methods for analyte detection" and "Multicomponent nucleic acid probes for sample analysis." The first patent provides methods, systems, and compositions for detecting nucleic acid sequences in a biological sample that has a three-dimensional matrix. It also outlines methods for processing biological samples for nucleic acid sequence detection. The second patent focuses on analyzing target molecules using probes that comprise multiple components, allowing for in situ analysis of target molecules within a sample.

Career Highlights

Shoshoni Droz is currently employed at 10X Genomics, Inc., where he continues to push the boundaries of scientific research. His work has been instrumental in advancing methodologies for nucleic acid detection, which has broad applications in various fields, including diagnostics and research.

Collaborations

Droz has collaborated with notable colleagues such as Richard Terry and Evan Daugharthy. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Shoshoni Droz is a distinguished inventor whose work in nucleic acid detection has made a significant impact in the scientific community. His patents reflect a commitment to advancing technology in biological analysis, and his collaborations further enhance his contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…